MetLife Investment Management LLC boosted its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) by 37.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,712 shares of the company’s stock after purchasing an additional 7,251 shares during the quarter. MetLife […]